Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

As companies chase efficiency, it's no surprise that today's customer service call is more likely to be answered by a bot than by the much-maligned, outsourced operators of the past. Executives ...

Cofense, a leader in intelligence-driven phishing defense, is enhancing its portfolio, introducing Smart Reinforcement within its Security Awareness Training solution, and unveiling the latest release ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Goldman's profit rose to $4.74 billion, or $14.12 per share, for the three months ended March 31, the bank said. That compared with $4.13 billion, or $11.58 per share, a year earlier. Morgan Stanley's ...